Brother Industries Chooses Kinaxis for Supply Chain Transformation
Kinaxis® Inc. (TSX: KXS), a global leader in end-to-end supply chain orchestration, today announced that Brother, a Japanese multinational electronics and electrical equipment company, has selected Kinaxis to increase visibility and collaboration within its global supply chain, improve demand forecasting and create more accurate and agile scenario planning.
Brother operates manufacturing, development and sales facilities in more than 40 countries across the globe and exceeds ¥80 billion in worldwide sales with its wide range of products and services including printers, labeling systems, industrial and home sewing machines, garment printers, digital printing equipment, and more. The company required a supply chain management solution that could account for its expansive range of products and multitude of industry-specific challenges, provide complete end-to-end visibility and match its innovative approach to problem-solving.
“From the beginning, Kinaxis demonstrated a clear understanding of our business and all its complexities. From there we formed a partnership based on trust and a passion for innovative solutions, like their unique approach to supply chain orchestration, which made the decision to go forward with this transformation easy,” said Kosaku Sakai, production strategy planning department manager at Brother Industries, LTD. “We are excited for our supply chain to be more efficient and more adaptable to change as we continue to grow. Our number one priority is our customers, and we are eager to provide more value for them with Kinaxis.”
“In an industry with so many moving pieces, not having the right software in place makes it easy for things to get missed and for disruption in one area of the supply chain to drastically impact another. The only way to manage it is with complete visibility,” said Toshiya Kaneko, president at Kinaxis Japan. “We are thrilled to be working with Brother to confidently orchestrate their entire supply chain – allowing them to continue to expand and deliver more value to their customers.”
With more than 40,000 users in 100+ countries, Kinaxis works with some of the world’s biggest brands in sectors such as CPG, automotive, high tech, life sciences, and more. Its AI-powered technology and patented concurrency technique allows companies to orchestrate their supply chain network end to end from strategic planning to last-mile delivery. Kinaxis’ technology helps companies that supply the agricultural industry with 40% of the world’s tractors, that keep more than 110 billion teeth clean each year, and that ensures more than 35 million pets are fed nutritious meals each year.
About Kinaxis
Kinaxis is a global leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them, in service of humanity. Our powerful, AI-infused supply chain orchestration platform, Maestro™ , combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn.
About Brother International Corporation
Brother International Corporation has earned its reputation as a premier provider of home office and business products, products for the sewing and crafting enthusiast as well as industrial solutions that revolutionize the way we live and work. Brother International Corporation is a wholly owned subsidiary of Brother Industries Ltd. With worldwide sales exceeding $6 billion, this global manufacturer was started more than 100 years ago. Bridgewater, New Jersey is the corporate headquarters for Brother in the Americas. It has fully integrated sales, marketing services, manufacturing, research, and development capabilities located in the U.S. In addition to its headquarters, Brother has facilities in California, Illinois, and Tennessee, as well as subsidiaries in Canada, Brazil, Chile, Argentina, Peru, and Mexico. For more information, visit www.brother.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240822056955/en/
Contacts
Media Relations
Jaime Cook | Kinaxis
jcook@kinaxis.com
289-552-4640
Investor Relations
Rick Wadsworth | Kinaxis
rwadsworth@kinaxis.com
613-907-7613
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Delta-Fly Pharma Inc.: Phase I/II Combo-study of DFP-10917 with Venetoclax in Patients with AML Initiates Enrollment of Patients10.9.2024 14:00:00 EEST | Press release
Following to the previous information on April 8th. 2024, we are excited to share our latest development status. A Phase I/II clinical trial of DFP-10917 in combination with Venetoclax (VEN) in patients with acute myeloid leukemia (AML) who had one prior treatment with VEN involved regimen was approved by the US Food and Drug Administration (FDA) on April 8 this year (Delta-Fly Pharma Inc.: Notice of Authorization to Conduct the Phase I/II Study of DFP-10917 combined with Venetoclax | Business Wire). Subsequently, we are pleased to announce that the first patient was enrolled at the University of Virginia Hospital based on the approval of the Investigational Review Board (IRB). The University of Virginia Hospital is the clinical site that enrolled the most patients to the Phase III study of DFP-10917 monotherapy in patients with failed/relapsed AML. Some pharmaceutical companies have already expressed interest in the Phase III study of DFP-10917 monotherapy. Additionally, many companie
SLB achieves breakthrough results in sustainable lithium production10.9.2024 13:56:00 EEST | Press release
SLB today announced it has proven its solution for sustainable lithium production at scale at its demonstration plant in Clayton Valley, Nevada, to accelerate responsibly-sourced lithium products to market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240909767336/en/ SLB's demonstration plant in Clayton Valley proves its unique integrated approach to produce scalable quantities of lithium in the fastest, most economical and sustainable way for today’s market. (Photo: Business Wire) The proprietary integrated solution combines SLB’s subsurface expertise with surface engineering of advanced technologies that include direct lithium extraction (DLE). It produces lithium 500 times faster than conventional methods while using only 10 percent of the land. Operating at approximately one tenth the size of a commercial-scale facility, the plant reached a verified recovery rate1 of 96% lithium from brine. SLB’s integrated solution i
Eaton to Showcase Technologies for Hydrogen-Powered Commercial Vehicles at IAA Transportation 202410.9.2024 13:30:00 EEST | Press release
Intelligent power management company Eaton announced it will showcase a broad range of innovative solutions for hydrogen-powered commercial vehicles September 17–22 at IAA Transportation 2024 in Hanover, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240910157651/en/ Eaton’s hydrogen recirculation blower cycles surplus hydrogen to the stack's inlet, which extends system longevity through anode purging. (Photo: Business Wire) “Eaton believes that hydrogen can play a significant role in decarbonizing commercial vehicles,” said Scott Adams, senior vice president, Global Products, Eaton’s Mobility Group. “Whether a vehicle is powered by hydrogen fuel cells or a hydrogen internal combustion engine, Eaton’s broad range of innovative solutions makes us a valuable supplier partner.” Eaton’s TVS technology improves fuel cell performance Recirculating excess hydrogen through the fuel cell stack is critical for achieving high
The LYCRA Company Presents Seminars on Sustainable Elastane Solutions at the 63rd Dornbirn Global Fiber Congress10.9.2024 12:00:00 EEST | Press release
The LYCRA Company, a global leader in developing innovative and sustainable fiber and technology solutions for the apparel and personal care industries, announced today that company representatives will give presentations at the Dornbirn Global Fiber Congress (GFC), September 11 - 13 in Dornbirn, Austria. These presentations cover two key initiatives within the roadmap and vision of The LYCRA Company’s Planet Agenda platform and 2030 Sustainability Goals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240910079150/en/ The LYCRA Company Presents Seminars on Sustainable Elastane Solutions at the 63rd Dornbirn Global Fiber Congress (Photo: Business Wire) Jean Hegedus, The LYCRA Company’s director of sustainable business development, will present “From Farm to Fiber: Developing Elastane with 70% Bio-Derived Content” on September 11 at 14:20 CEST (Kulturhaus Room B). She will be joined by Andrea Vanderhoff, director of technology
CorFlow Therapeutics AG Completes €44 Million Series B Financing to Support the Advancement of a Novel Diagnostic and Drug Delivery Platform for Microvascular Obstruction (MVO) in Heart Attack Patients10.9.2024 11:00:00 EEST | Press release
CorFlow Therapeutics AG (CorFlow) announced today that it has raised €44 million in Series B funding, co-led by Broadview Ventures and Panakes Partners with strong continued support from 415 Capital, CorFlow's initial VC investor and largest shareholder. Merieux Equity Partners, Laerdal Million Lives Fund, Wellington Partners, M&L Investments, Unorthodox Ventures, KOFA Healthcare and Monte Carlo Capital participated in the multinational syndicate. Concurrent with the financing, David Prim of Broadview Ventures, Barbara Castellano of Panakes Partners, Yoann Bonnamour of Merieux Equity Partners, and Rhiya Pau of Laerdal Million Lives Fund have joined the CorFlow Board of Directors. The Series B will fund the MOCA II (MVO with CoFITM System Assessment II) pivotal study intended to gain US market clearance. The trial will run in the US and Europe and aims to validate CorFlow’s CoFl system to diagnose MVO in heart attack patients immediately following stent implantation. Additionally, it wi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom